Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Jul-21 5:34 PM View:  | Goldsmith Mark A Director | Constellation Pharmaceutica... (CNST) | 15-Jul-21 | Disposition | 89,857 | -- | -- | (100%) 89.86K to 0 | |
| 19-Jul-21 5:29 PM View: | Audia James E Director | Constellation Pharmaceutica... (CNST) | 15-Jul-21 | Disposition | 25,434 | -- | -- | (100%) 25.43K to 0 | |
| 19-Jul-21 5:37 PM View: | Raythatha Jigar See Remarks Director | Constellation Pharmaceutica... (CNST) | 15-Jul-21 | Disposition | 14,961 | -- | -- | (100%) 14.96K to 0 | |
| 08-Mar-21 5:44 PM View: | Goldsmith Mark A Director | Constellation Pharmaceutica... (CNST) | 04-Mar-21 | Option Exercise | 14,987 | -- | -- | 20% 74.87K to 89.86K | |
| 23-Feb-21 5:58 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 22-Feb-21 | Option Exercise | 6,260 | $8.04 | $50,330.40 | 100% 0 to 6.26K | |
| 23-Feb-21 5:58 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 22-Feb-21 | Planned Option Sale | 6,260 | $37.60 | $235,374.00 | (100%) 6.26K to 0 | |
| 23-Feb-21 5:58 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 19-Feb-21 | Planned Option Sale | 4,010 | $37.71 | $151,218.00 | (100%) 4.01K to 0 | |
| 23-Feb-21 5:58 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 19-Feb-21 | Option Exercise | 4,010 | $8.04 | $32,240.40 | 100% 0 to 4.01K | |
| 19-Feb-21 4:17 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 18-Feb-21 | Planned Option Sale | 1,100 | $37.58 | $41,343.10 | (100%) 1.1K to 0 | |
| 19-Feb-21 4:17 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 18-Feb-21 | Option Exercise | 1,100 | $8.04 | $8,844.00 | 100% 0 to 1.1K | |
| 19-Feb-21 4:17 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 17-Feb-21 | Option Exercise | 410 | $8.04 | $3,296.40 | 100% 0 to 0.41K | |
| 19-Feb-21 5:31 PM View: | Column Group L P 10% Owner | Constellation Pharmaceutica... (CNST) | 17-Feb-21 | Private Sale | 10,000 | $36.95 | $369,503.00 | (< 1%) 6.24M to 6.23M | |
| 19-Feb-21 5:32 PM View: | Column Group L P 10% Owner | Constellation Pharmaceutica... (CNST) | 17-Feb-21 | Private Sale Duplicate | 10,000 | $36.95 | $369,503.00 | (< 1%) 6.24M to 6.23M | |
| 19-Feb-21 4:17 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 17-Feb-21 | Planned Option Sale | 410 | $37.56 | $15,397.80 | (100%) 0.41K to 0 | |
| 20-Jan-21 5:56 PM View: | Valentine Karen See Remarks | Constellation Pharmaceutica... (CNST) | 19-Jan-21 | Option Exercise | 17,203 | $11.50 | $197,834.00 | 100% 0 to 17.2K | |
| 20-Jan-21 5:56 PM View: | Valentine Karen See Remarks | Constellation Pharmaceutica... (CNST) | 19-Jan-21 | Planned Option Sale | 17,203 | $33.97 | $584,463.00 | (100%) 17.2K to 0 | |
| 08-Mar-21 10:00 PM View: | Goldsmith Mark A Director | Constellation Pharmaceutica... (CNST) | 25-Dec-20 | Gift | 64,173 | -- | -- | (46%) 139.04K to 74.87K | |
| 22-Dec-20 4:53 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 21-Dec-20 | Planned Option Sale | 5,720 | $35.11 | $200,805.00 | (100%) 5.72K to 0 | |
| 22-Dec-20 4:53 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 21-Dec-20 | Option Exercise | 5,720 | $6.81 | $38,975.40 | 100% 0 to 5.72K | |
| 28-Dec-20 4:02 PM View: | Goldsmith Mark A Director | Constellation Pharmaceutica... (CNST) | 21-Dec-20 | Private Sale (Planned) | 4,020 | $35.02 | $140,769.00 | (3%) 143.06K to 139.04K | |
| 16-Dec-20 6:40 PM View: | Column Group L P 10% Owner | Constellation Pharmaceutica... (CNST) | 14-Dec-20 | Exercise (in-the money or at-the-money) | 30,107 | $1.55 | $46,665.80 | < 1% 6.21M to 6.24M | |
| 16-Dec-20 6:42 PM View: | Column Group L P 10% Owner | Constellation Pharmaceutica... (CNST) | 14-Dec-20 | Exercise (in-the money or at-the-money) Duplicate | 30,107 | $1.55 | $46,665.80 | < 1% 6.21M to 6.24M | |
| 26-Jan-21 10:00 PM View: | Goldsmith Mark A Director | Constellation Pharmaceutica... (CNST) | 27-Oct-20 | Gift | 2,000 | -- | -- | 1% 139.04K to 141.04K | |
| 26-Jan-21 10:00 PM View: | Goldsmith Mark A Director | Constellation Pharmaceutica... (CNST) | 27-Oct-20 | Gift | 2,000 | -- | -- | (1%) 141.04K to 139.04K | |
| 10-Jun-20 6:50 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 08-Jun-20 | Planned Option Sale | 589 | $37.55 | $22,117.60 | (100%) 0.59K to 0 | |
| 10-Jun-20 6:50 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 08-Jun-20 | Option Exercise | 589 | $7.60 | $4,476.40 | 100% 0 to 0.59K | |
| 13-May-20 6:29 PM View: | Goldsmith Mark A Director 10% Owner | Constellation Pharmaceutica... (CNST) | 12-May-20 | Planned Option Sale | 4,225 | $50.05 | $211,474.00 | (3%) 147.29K to 143.06K | |
| 13-May-20 6:25 PM View: | Raythatha Jigar See Remarks Director | Constellation Pharmaceutica... (CNST) | 12-May-20 | Option Exercise | 9,209 | $5.51 | $50,741.60 | 62% 14.96K to 24.17K | |
| 13-May-20 6:29 PM View: | Goldsmith Mark A Director 10% Owner | Constellation Pharmaceutica... (CNST) | 12-May-20 | Option Exercise | 4,225 | $4.12 | $17,398.80 | 3% 143.06K to 147.29K | |
| 13-May-20 6:30 PM View: | Audia James E Director | Constellation Pharmaceutica... (CNST) | 12-May-20 | Private Sale (Planned) | 6,100 | $50.10 | $305,622.00 | (19%) 31.53K to 25.43K | |
| 13-May-20 6:30 PM View: | Senderowicz Adrian Chief Medical Officer | Constellation Pharmaceutica... (CNST) | 12-May-20 | Planned Option Sale | 9,357 | $50.18 | $469,488.00 | (37%) 25.24K to 15.88K | |
| 13-May-20 6:30 PM View: | Senderowicz Adrian Chief Medical Officer | Constellation Pharmaceutica... (CNST) | 12-May-20 | Option Exercise | 9,357 | $5.51 | $51,557.10 | 59% 15.88K to 25.24K | |
| 13-May-20 6:25 PM View: | Raythatha Jigar See Remarks Director | Constellation Pharmaceutica... (CNST) | 12-May-20 | Planned Option Sale | 9,209 | $50.17 | $461,981.00 | (38%) 24.17K to 14.96K | |
| 12-May-20 9:41 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 11-May-20 | Option Exercise | 16,062 | $8.92 | $143,269.00 | 100% 0 to 16.06K | |
| 13-May-20 6:25 PM View: | Raythatha Jigar See Remarks Director | Constellation Pharmaceutica... (CNST) | 11-May-20 | Planned Option Sale | 26 | $50.00 | $1,300.00 | (< 1%) 14.99K to 14.96K | |
| 13-May-20 6:29 PM View: | Goldsmith Mark A Director 10% Owner | Constellation Pharmaceutica... (CNST) | 11-May-20 | Planned Option Sale | 100 | $50.00 | $5,000.00 | (< 1%) 143.16K to 143.06K | |
| 13-May-20 6:25 PM View: | Raythatha Jigar See Remarks Director | Constellation Pharmaceutica... (CNST) | 11-May-20 | Option Exercise | 26 | $5.51 | $143.26 | < 1% 14.96K to 14.99K | |
| 12-May-20 9:41 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 11-May-20 | Planned Option Sale | 16,062 | $49.53 | $795,623.00 | (100%) 16.06K to 0 | |
| 13-May-20 6:29 PM View: | Goldsmith Mark A Director 10% Owner | Constellation Pharmaceutica... (CNST) | 11-May-20 | Option Exercise | 100 | $1.55 | $155.00 | < 1% 143.06K to 143.16K | |
| 12-May-20 9:41 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 08-May-20 | Planned Private Option Sale | 12,741 | $49.53 | $631,055.00 | (100%) 12.74K to 0 | |
| 12-May-20 9:41 PM View: | Reeve Emma Chief Financial Officer | Constellation Pharmaceutica... (CNST) | 08-May-20 | Option Exercise | 12,741 | $9.85 | $125,467.00 | 100% 0 to 12.74K | (5%) |
| 07-May-20 4:34 PM View: | Valentine Karen See Remarks | Constellation Pharmaceutica... (CNST) | 06-May-20 | Option Exercise | 12,566 | $10.96 | $137,749.00 | 100% 0 to 12.57K | |
| 07-May-20 4:34 PM View: | Valentine Karen See Remarks | Constellation Pharmaceutica... (CNST) | 06-May-20 | Planned Option Sale | 12,566 | $40.10 | $503,897.00 | (100%) 12.57K to 0 | |
| 07-May-20 4:25 PM View: | Goldsmith Mark A Director 10% Owner | Constellation Pharmaceutica... (CNST) | 06-May-20 | Planned Option Sale | 11,463 | $45.06 | $516,545.00 | (7%) 154.53K to 143.06K | |
| 07-May-20 4:25 PM View: | Goldsmith Mark A Director 10% Owner | Constellation Pharmaceutica... (CNST) | 06-May-20 | Option Exercise | 11,463 | $4.26 | $48,825.20 | 8% 143.06K to 154.53K | |
| 07-May-20 4:39 PM View: | Trojer Patrick Chief Scientific Officer | Constellation Pharmaceutica... (CNST) | 06-May-20 | Planned Option Sale | 10,000 | $45.16 | $451,553.00 | (100%) 10.0K to 0 | |
| 07-May-20 4:39 PM View: | Trojer Patrick Chief Scientific Officer | Constellation Pharmaceutica... (CNST) | 06-May-20 | Option Exercise | 10,000 | $7.04 | $70,384.70 | 100% 0 to 10.0K | |
| 07-May-20 4:28 PM View: | Audia James E Director | Constellation Pharmaceutica... (CNST) | 06-May-20 | Private Sale (Planned) | 7,500 | $45.15 | $338,600.00 | (19%) 39.03K to 31.53K | |
| 07-May-20 4:25 PM View: | Goldsmith Mark A Director 10% Owner | Constellation Pharmaceutica... (CNST) | 05-May-20 | Option Exercise | 3,145 | $3.50 | $11,005.80 | 2% 143.06K to 146.21K | |
| 07-May-20 4:34 PM View: | Valentine Karen See Remarks | Constellation Pharmaceutica... (CNST) | 05-May-20 | Option Exercise | 4,744 | $11.50 | $54,556.00 | 100% 0 to 4.74K |
